Armistice Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
124,000
+54,933
| +80% | +$1.42M | 0.06% | 112 |
|
|
2025
Q1 | $704K | Buy |
69,067
+800
| +1% | +$8.16K | 0.01% | 169 |
|
|
2024
Q4 | $952K | Buy |
68,267
+1,600
| +2% | +$22.3K | 0.01% | 165 |
|
|
2024
Q3 | $1.3M | Buy |
66,667
+10,934
| +20% | +$213K | 0.02% | 163 |
|
|
2024
Q2 | $1.04M | Buy |
+55,733
| New | +$1.04M | 0.01% | 159 |
|